share_log

Puma Biotechnology Says NCCN Clinical Practice Adds Breast Cancer Drug Nerlynx to Guidelines

Puma Biotechnology Says NCCN Clinical Practice Adds Breast Cancer Drug Nerlynx to Guidelines

Puma Biotechnology 表示 NCCN 临床实践将乳腺癌药物 Nerlynx 添加到指南中
MT Newswires ·  2023/02/01 16:14

Unity Software(U.US) reported fourth-quarter financial results after the market close on Monday. Here's a rundown of the report.Q4 Earnings: Unity said fourth-quarter revenue increased 35% year-over-year to $609 million, beating the consensus estimate of $562.71 million. The company reported a quarterly loss of 66 cents per share.

声明:本内容仅用作提供资讯及教育之目的,不构成对任何特定投资或投资策略的推荐或认可。 更多信息
    抢沙发